Sign in

PCYN on OTC

PROCYON CORP

PROCYON CORP is an American pharmaceutical preparations company, incorporated in Colorado.1 It is headquartered in Clearwater, Florida.1 Its shares trade on OTC under the symbol PCYN.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$5.0MRevenue, fiscal 20242
-$341.1KNet income, fiscal 20242

Compare with Adlai Nortye Group Ltd., InMed Pharmaceuticals Inc. or SPRUCE BIOSCIENCES, INC., or pick any stock.

  • TickerPCYN on OTC1
  • IndustryPharmaceutical Preparations1
  • HeadquartersClearwater, Florida1
  • Incorporated inCO3
  • Business address1300 S Highland Ave, Clearwater, Fl 337563
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Procyon, a Colorado corporation, was incorporated on March 19, 1987, and was deemed a development stage company until May 1996, when we acquired Amerx, a corporation based in Oldsmar, Florida, which was wholly owned by John C. Anderson, our deceased Chief Executive Officer. AMERX® develops and markets proprietary medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Historically, AMERX's products are sold through distributors to healthcare institutions including hospitals, wound care clinics, nursing homes and home health care agencies and to retailers including national and regional chain stores and pharmacies and to healthcare practitioners who treat wounds. Sirius no longer has any material operations.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

78.1%Gross margin2
-4.6%Operating margin2
-6.8%Net margin2
6.4%Revenue growth, 20242
-14.9%Return on equity2
-$125.2KFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue22¢$1.1M
  • Research and development1¢$30.1K
  • Selling, general and admin41¢$2.0M
  • Other costs33¢$1.7M
  • Income tax3¢$169.9K

Out of $5.0M in revenue.2 The company lost money this year.

Financial statements

Revenue56789102$5.0M in 2024+24% since 2017
0$2.0M$4.0M$6.0M2017: $4.0M$4.0M20172018: $4.0M$4.0M2018+0%2019: $4.2M$4.2M2019+4%2020: $4.3M$4.3M2020+3%2021: $4.7M$4.7M2021+9%2022: $4.8M$4.8M2022+3%2023: $4.7M$4.7M2023−3%2024: $5.0M$5.0M2024+6%
Gross profit56789102$3.9M in 2024+42% since 2017
0$1.0M$2.0M$3.0M$4.0M2017: $2.7M$2.7M20172018: $2.9M$2.9M2018+7%2019: $3.0M$3.0M2019+4%2020: $3.2M$3.2M2020+5%2021: $3.4M$3.4M2021+6%2022: $3.5M$3.5M2022+3%2023: $3.6M$3.6M2023+2%2024: $3.9M$3.9M2024+9%
Operating income56789102-$231.7K in 2024
-$400.0K-$200.0K0$200.0K$400.0K2017: $30.0K$30.0K20172018: $127.1K$127.1K2018+324%2019: $97.1K$97.1K2019−24%2020: $153.0K$153.0K2020+58%2021: $226.7K$226.7K2021+48%2022: -$237.2K-$237.2K20222023: -$97.4K-$97.4K2023−59%2024: -$231.7K-$231.7K2024+138%
Net income56119102-$341.1K in 2024
-$500.0K0$500.0K$1.0M2017: $12.4K$12.4K20172018: -$255.7K-$255.7K20182019: $83.6K$83.6K20192020: $293.4K$293.4K2020+251%2021: $694.3K$694.3K2021+137%2022: -$209.8K-$209.8K20222023: -$50.2K-$50.2K2023−76%2024: -$341.1K-$341.1K2024+579%
Fiscal year20172018201920202021202220232024
Revenue$4.0M5$4.0M6$4.2M7$4.3M8$4.7M9$4.8M10$4.7M2$5.0M2
Cost of revenue$1.3M5$1.1M6$1.1M7$1.1M8$1.3M9$1.4M10$1.1M2$1.1M2
Gross profit$2.7M5$2.9M6$3.0M7$3.2M8$3.4M9$3.5M10$3.6M2$3.9M2
Research and development$31.3K5$41.7K6$33.1K7$23.1K8$30.9K9$30.0K10$30.6K2$30.1K2
Selling, general and admin$1.2M5$1.3M6$1.4M7$1.3M8$1.3M9$1.7M10$1.8M2$2.0M2
Operating income$30.0K5$127.1K6$97.1K7$153.0K8$226.7K9-$237.2K10-$97.4K2-$231.7K2
Interest$2.8K5$06$07$014$2.2K9$09
Income before tax-$235.4K10-$65.4K2-$171.3K2
Income tax$16.6K5$383.4K6$72.1K7$48.4K8$39.4K9-$25.6K10-$15.1K2$169.9K2
Net income$12.4K5-$255.7K6$83.6K11$293.4K11$694.3K9-$209.8K10-$50.2K2-$341.1K2
Earnings per share$0.005-$0.036$0.007$0.018$0.089-$0.0310-$0.012-$0.042
Earnings per share (diluted)$0.005-$0.036$0.007$0.018$0.089-$0.0310-$0.012-$0.042
Shares (weighted, basic)8.1M shares108.1M shares28.1M shares2
Shares (weighted, diluted)8.1M shares108.1M shares28.1M shares2

Compare PROCYON CORP with another company

Corporate structure

PROCYON CORP sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of PROCYON CORP

  • SPEER FOUNDATION Filed SC 13G/A on PROCYON CORP, latest Jan 4, 2024 (3 filings since Jan 13, 2022)
  • PROCYON CORP Clearwater, Florida

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What PROCYON CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$558.7K2 Jun 30, 2024$606.9K2 Jun 30, 2023−7.9%
Accumulated depreciation$296.7K2 Jun 30, 2024$325.9K2 Jun 30, 2023−9.0%
Property and equipment, net$262.0K2 Jun 30, 2024$281.0K2 Jun 30, 2023−6.8%
Operating-lease assets (leased space)$338.1K2 Jun 30, 2024$527.2K2 Jun 30, 2023−35.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Finite-lived intangibles, net$17.0K2 Jun 30, 2024$17.0K2 Jun 30, 20230%

Inventory

ItemLatestA year beforeChange
Inventory, total$510.0K2 Jun 30, 2024$431.4K2 Jun 30, 2023+18.2%
Raw materials$97.0K2 Jun 30, 2024$185.4K2 Jun 30, 2023−47.7%
Finished goods$629.8K2 Jun 30, 2024$576.5K2 Jun 30, 2023+9.2%

Properties, in its own words

We currently maintain our corporate office, and those of AMERX and Sirius, at 164 Douglas Road East, Suite 164, Oldsmar, Florida 34677. Our office consists of approximately 18,000 square feet of space. We have entered into a five year lease which commenced in January 2021.

On January 13, 2021 the Company entered into a lease agreement to lease 18,000 square feet of warehouse space in Oldsmar, FL. The lease is is for a five year term starting May 1, 2021 and ending April 30, 2026. The lease payment begins at $14,165 per month and will increase annually based on the Consumer Price Index, and will be no less then 2% or exceed 5% per year.

Item 2 of the 10-K filed Oct 25, 2024.4

Leadership

Who has led PROCYON CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Regina Wolfe Anderson2006–2007
  2. Justice Wolfe Anderson2021

President

  1. Regina Wolfe Anderson2006–2007
2010201520202025
Board members and other officers (11)

Timeline

  1. Nov 8, 20248-K Other events28
  2. Oct 22, 20248-K Other events29
  3. Aug 2, 20238-K Entered a material agreement; Executive or director change30
  4. Jan 13, 20238-K Shareholder vote31
  5. Nov 15, 20218-K Shareholder vote32
  6. Oct 4, 2021New chief executive Justice Wolfe Anderson becomes CEO16
  7. Jul 18, 2006New chief executive Regina Wolfe Anderson becomes CEO17

Filings

51 filings to the SEC since October 2021: 5 annual reports, 9 quarterly reports, 5 major events, 16 insider forms, 3 large holders, 13 other. The latest 20:

  1. Nov 8, 202415-12G EDGAR
  2. Nov 8, 20248-K EDGAR
  3. Oct 25, 202410-K EDGAR
  4. Oct 23, 20244 EDGAR
  5. Oct 23, 20244 EDGAR
  6. Oct 23, 20244 EDGAR
  7. Oct 23, 20244 EDGAR
  8. Oct 22, 20248-K EDGAR
  9. Sep 30, 2024NT 10-K EDGAR
  10. Jun 27, 20244 EDGAR
  11. Jun 26, 2024144 EDGAR
  12. Jun 25, 2024144 EDGAR
  13. May 24, 202410-Q EDGAR
  14. May 20, 2024NT 10-Q EDGAR
  15. Feb 22, 202410-Q EDGAR
  16. Feb 13, 2024NT 10-Q EDGAR
  17. Jan 4, 2024SC 13G/A EDGAR
  18. Nov 22, 202310-Q EDGAR
  19. Nov 14, 2023NT 10-Q EDGAR
  20. Oct 25, 2023DEFR14A EDGAR

The 51 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

5 open-market trades by officers, directors and large owners since October 2021: 0 buys and 5 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 26, 2024SPEER FOUNDATION10% ownerSale40,000$0.18$7.2KForm 4
Jun 25, 2024SPEER FOUNDATION10% ownerSale40,000$0.19$7.6KForm 4
Mar 31, 2022SPEER FOUNDATION10% ownerSale40,000$0.38$15.2KForm 4
Feb 7, 2022SPEER FOUNDATION10% ownerSale15,000$0.35$5.2KForm 4
Dec 6, 2021SPEER FOUNDATION10% ownerSale25,000$0.32$8.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How PROCYON CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPROCYON CORP1
  • CIK0000812306
  • Employer ID (EIN)59-32808224
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
  • Incorporated inColorado4
  • Fiscal year endsJune 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address1300 S Highland Ave, Clearwater, FL 337561
  • Phone(727)447-29981
  • Shares outstanding8,120,388 shares as of Sep 28, 20244
  • Public float$1.0M as of Sep 24, 20244
  • AuditorFerlita, Walsh, Gonzalez & Rodriguez, P.A., Tampa, Florida PCAOB ID 232; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceMay 15, 19961
  • Filings297 in all: 10-Q (49), 10QSB (37), 8-K (37), 4 (33), DEF 14A (26), 10-K (17), NT 10-Q (16), 10KSB (12)1
    All 27 form types

    3 (12), ARS (11), NT 10-K (10), 10KSB/A (6), SC 13D (4), SC 13G/A (4), 8-K/A (3), DEFR14A (3), 10-K/A (2), 10-Q/A (2), 10QSB/A (2), 144 (2), SC 13D/A (2), SC 13G (2), 15-12G (1), CORRESP (1), CT ORDER (1), S-8 (1), UPLOAD (1)

  • Latest filingsAnnual report (10-K) Oct 25, 2024
    Quarterly report (10-Q) May 24, 2024
    Proxy statement (DEF 14A) Oct 12, 2023
    Latest 8-K (8-K) Nov 8, 2024

Risk factors and legal proceedings

Legal proceedings

The Company and its subsidiaries are not a party to any pending material legal proceedings nor is our property the subject of a pending legal proceeding.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
    SEC EDGAROther events
  29. 29
    SEC EDGAROther events
  30. 30
  31. 31
  32. 32
  33. 33